Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 17, 2025

Primary Completion Date

December 31, 2032

Study Completion Date

December 31, 2032

Conditions
Breast CancerAxillary Lymph Nodes DissectionAxillary MetastasesSentinel Lymph Node Biopsy (SLNB)Node Positive Breast CancerAxilla; BreastAxillary Ultrasound
Interventions
PROCEDURE

Targeted Sentinel Node Biopsy (TSNB)

Targeted Sentinel Node Biopsy will be performed according to routine local practice. The procedure has been standardised for the post-NACT setting as part of the ongoing ATNEC trial. Sites are advised to follow the ATNEC protocol in the primary surgery setting, using either a dual- or single-tracer sentinel node biopsy technique, with localisation and removal of the marked biopsy proven positive node, and removal of at least 3 nodes.

Trial Locations (7)

Unknown

RECRUITING

Burnley General Teaching Hospital, Burnley

RECRUITING

Addenbrooke's Hospital, Cambridge

RECRUITING

Royal Derby Hospital, Derby

RECRUITING

Gartnavel General Hospital, Glasgow

RECRUITING

Royal Alexandra Hospital, Paisley

RECRUITING

Mersey and West Lancashire Teaching Hospitals, St Helens

HP11 2TT

RECRUITING

Wycombe Hospital, High Wycombe

All Listed Sponsors
lead

University Hospitals of Derby and Burton NHS Foundation Trust

OTHER